Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of STAP1 mRNA | CTD | PMID:36331819 | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of STAP1 mRNA | CTD | PMID:30723492 | 17beta-estradiol | multiple interactions | ISO | STAP1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of STAP1 mRNA | CTD | PMID:21453500 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Stap1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STAP1 mRNA | CTD | PMID:28922406 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STAP1 mRNA | CTD | PMID:34747641 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Stap1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of STAP1 mRNA | CTD | PMID:20188158 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of STAP1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of STAP1 gene | CTD | PMID:27153756 | Aflatoxin B2 alpha | decreases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of STAP1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of STAP1 mRNA | CTD | PMID:33167477 | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of STAP1 mRNA | CTD | PMID:35163327 | arsenous acid | increases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of STAP1 mRNA | CTD | PMID:15761015 | benzo[a]pyrene | affects methylation | ISO | STAP1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of STAP1 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of STAP1 5' UTR | CTD | PMID:27901495 | benzo[e]pyrene | decreases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of STAP1 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of STAP1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of STAP1 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of STAP1 mRNA | CTD | PMID:34947998 | bisphenol F | decreases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | bisphenol F results in decreased methylation of STAP1 gene | CTD | PMID:31601247 | buta-1,3-diene | decreases expression | ISO | Stap1 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of STAP1 mRNA | CTD | PMID:29038090 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of STAP1 promoter | CTD | PMID:22457795 | carbon nanotube | decreases expression | ISO | Stap1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | STAP1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to STAP1 gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | Stap1 (Mus musculus) | 6480464 | Chlordecone results in increased expression of STAP1 mRNA | CTD | PMID:33711761 | chloroprene | decreases expression | ISO | Stap1 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of STAP1 mRNA | CTD | PMID:23125180 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of STAP1 mRNA | CTD | PMID:23640034 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of STAP1 mRNA | CTD | PMID:23914054 | diarsenic trioxide | increases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of STAP1 mRNA | CTD | PMID:15761015 | dimethylarsinic acid | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA | CTD | PMID:34876320 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of STAP1 mRNA | CTD | PMID:29391264 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of STAP1 mRNA | CTD | PMID:30307764 | formaldehyde | decreases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of STAP1 mRNA | CTD | PMID:27905399 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of STAP1 gene | CTD | PMID:22079235 | inulin | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of STAP1 mRNA | CTD | PMID:36331819 | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of STAP1 mRNA | CTD | PMID:35283115 | lipopolysaccharide | multiple interactions | ISO | STAP1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STAP1 mRNA | CTD | PMID:35811015 | methapyrilene | decreases methylation | ISO | STAP1 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of STAP1 intron | CTD | PMID:30157460 | methotrexate | increases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of STAP1 mRNA | CTD | PMID:24449571 | methylarsonic acid | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA | CTD | PMID:34876320 | nickel atom | increases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Nickel results in increased expression of STAP1 mRNA | CTD | PMID:24768652 | paracetamol | affects expression | ISO | Stap1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of STAP1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Stap1 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of STAP1 mRNA | CTD | PMID:34724096 | paracetamol | increases expression | ISO | STAP1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of STAP1 mRNA | CTD | PMID:26690555 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of STAP1 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of STAP1 mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of STAP1 mRNA] | CTD | PMID:19482888 | phenobarbital | decreases expression | ISO | Stap1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of STAP1 mRNA | CTD | PMID:19482888 | pirinixic acid | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of STAP1 mRNA | CTD | PMID:20813756 | pirinixic acid | decreases expression | ISO | Stap1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of STAP1 mRNA | CTD | PMID:20813756 | progesterone | multiple interactions | ISO | STAP1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of STAP1 mRNA | CTD | PMID:21453500 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | STAP1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STAP1 mRNA | CTD | PMID:35811015 | sodium arsenate | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA | CTD | PMID:34876320 | sodium arsenite | multiple interactions | ISO | Stap1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of STAP1 mRNA | CTD | PMID:34876320 | tamoxifen | decreases expression | ISO | Stap1 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of STAP1 mRNA | CTD | PMID:25123088 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of STAP1 mRNA | CTD | PMID:34492290 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of STAP1 gene | CTD | PMID:27618143 | valproic acid | affects expression | ISO | Stap1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of STAP1 mRNA | CTD | PMID:17292431 | |